EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.13.11.31 | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | IC50: 0.0007 mM | Homo sapiens | |
1.13.11.31 | 2,3,4,5-tetrabromo-6-(4,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.0041 mM | Homo sapiens | |
1.13.11.31 | 2,3,5-tribromo-6-(4,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.00041 mM | Homo sapiens | |
1.13.11.31 | 2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | IC50: 0.012 mM | Homo sapiens | |
1.13.11.31 | 2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | IC50: 0.007 mM | Homo sapiens | |
1.13.11.31 | 3,4,6,8-tetrabromooxanthren-1-ol | IC50: 0.05 mM | Homo sapiens | |
1.13.11.31 | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | IC50: 0.006 mM | Homo sapiens | |
1.13.11.31 | 3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | IC50: 0.047 mM | Homo sapiens | |
1.13.11.31 | 3,6,8-tribromooxanthren-1-ol | IC50: 0.03 mM | Homo sapiens | |
1.13.11.31 | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | IC50: 0.0004 mM | Homo sapiens | |
1.13.11.31 | 4,4'-propane-2,2-diylbis(2,6-dibromophenol) | IC50: 0.01 mM | Homo sapiens | |
1.13.11.31 | bestatin 7 | IC50: 0.0023 mM | Homo sapiens | |
1.13.11.31 | nordihydroguaiaretic acid | IC50: 0.0051 mM | Homo sapiens | |
1.13.11.33 | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | IC50: 0.007 mM | Glycine max | |
1.13.11.33 | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | IC50: 0.0018 mM | Homo sapiens | |
1.13.11.33 | 2,3,4,5-tetrabromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.00079 mM | Homo sapiens | |
1.13.11.33 | 2,3,5-tribromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | IC50: 0.0022 mM | Homo sapiens | |
1.13.11.33 | 2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | IC50: 0.01 mM | Homo sapiens | |
1.13.11.33 | 2,4-Dibromophenol | IC50: 0.034 mM | Homo sapiens | |
1.13.11.33 | 2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | IC50: 0.005 mM | Homo sapiens | |
1.13.11.33 | 3,4,6,8-tetrabromooxanthren-1-ol | IC50: 0.0009 mM | Homo sapiens | |
1.13.11.33 | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | IC50: 0.009 mM | Glycine max | |
1.13.11.33 | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | IC50: 0.005 mM | Homo sapiens | |
1.13.11.33 | 3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | IC50: 0.011 mM | Homo sapiens | |
1.13.11.33 | 3,6,8-tribromooxanthren-1-ol | IC50: 0.0008 mM | Homo sapiens | |
1.13.11.33 | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | IC50: 0.059 mM | Glycine max | |
1.13.11.33 | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | IC50: 0.059 mM | Homo sapiens | |
1.13.11.33 | 4,4'-propane-2,2-diylbis(2,6-dibromophenol) | IC50: 0.004 mM | Homo sapiens | |
1.13.11.33 | 4-Bromophenol | IC50: 0.048 mM | Glycine max | |
1.13.11.33 | 4-Bromophenol | IC50: 0.055 mM | Homo sapiens | |
1.13.11.33 | bestatin | IC50: 0.027 mM | Glycine max | |
1.13.11.33 | bestatin 7 | IC50: 0.027 mM | Homo sapiens | |
1.13.11.33 | additional information | IC50 above 0.1 mM: compound 1a, compound 1b, compound 1d, compound 1e, compound 1g | Homo sapiens | |
1.13.11.33 | nordihydroguaiaretic acid | IC50: 0.0018 mM | Glycine max | |
1.13.11.33 | nordihydroguaiaretic acid | IC50: 0.00011 mM | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.11.31 | Homo sapiens | - |
- |
- |
1.13.11.33 | Glycine max | - |
- |
- |
1.13.11.33 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.13.11.31 | blood platelet | - |
Homo sapiens | - |
1.13.11.33 | reticulocyte | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.11.31 | arachidonate + O2 | - |
Homo sapiens | (5Z,8Z,10E,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoate | - |
? | |
1.13.11.33 | linoleic acid + O2 | - |
Homo sapiens | 13-hydroperoxy-(9Z,11E)-linoleic acid | - |
? | |
1.13.11.33 | linoleic acid + O2 | - |
Glycine max | 13-hydroperoxy-(9Z,11E)-linoleic acid | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.13.11.31 | 12-hLO | - |
Homo sapiens |
1.13.11.31 | 12-LO | - |
Homo sapiens |
1.13.11.33 | 15-hLO | - |
Homo sapiens |
1.13.11.33 | 15-LO | - |
Homo sapiens |
1.13.11.33 | 15-LO | - |
Glycine max |
1.13.11.33 | 15-sLO | - |
Glycine max |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.13.11.31 | 0.0004 | - |
IC50: 0.0004 mM | Homo sapiens | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | |
1.13.11.31 | 0.00041 | - |
IC50: 0.00041 mM | Homo sapiens | 2,3,5-tribromo-6-(4,5-dibromo-2-hydroxyphenoxy)phenol | |
1.13.11.31 | 0.0007 | - |
IC50: 0.0007 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | |
1.13.11.31 | 0.0023 | - |
IC50: 0.0023 mM | Homo sapiens | bestatin 7 | |
1.13.11.31 | 0.0041 | - |
IC50: 0.0041 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(4,5-dibromo-2-hydroxyphenoxy)phenol | |
1.13.11.31 | 0.0051 | - |
IC50: 0.0051 mM | Homo sapiens | nordihydroguaiaretic acid | |
1.13.11.31 | 0.006 | - |
IC50: 0.006 mM | Homo sapiens | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | |
1.13.11.31 | 0.007 | - |
IC50: 0.007 mM | Homo sapiens | 2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | |
1.13.11.31 | 0.01 | - |
IC50: 0.01 mM | Homo sapiens | 4,4'-propane-2,2-diylbis(2,6-dibromophenol) | |
1.13.11.31 | 0.012 | - |
IC50: 0.012 mM | Homo sapiens | 2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | |
1.13.11.31 | 0.03 | - |
IC50: 0.03 mM | Homo sapiens | 3,6,8-tribromooxanthren-1-ol | |
1.13.11.31 | 0.047 | - |
IC50: 0.047 mM | Homo sapiens | 3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | |
1.13.11.31 | 0.05 | - |
IC50: 0.05 mM | Homo sapiens | 3,4,6,8-tetrabromooxanthren-1-ol | |
1.13.11.33 | 0.00011 | - |
IC50: 0.00011 mM | Homo sapiens | nordihydroguaiaretic acid | |
1.13.11.33 | 0.00079 | - |
IC50: 0.00079 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | |
1.13.11.33 | 0.0008 | - |
IC50: 0.0008 mM | Homo sapiens | 3,6,8-tribromooxanthren-1-ol | |
1.13.11.33 | 0.0009 | - |
IC50: 0.0009 mM | Homo sapiens | 3,4,6,8-tetrabromooxanthren-1-ol | |
1.13.11.33 | 0.0018 | - |
IC50: 0.0018 mM | Glycine max | nordihydroguaiaretic acid | |
1.13.11.33 | 0.0018 | - |
IC50: 0.0018 mM | Homo sapiens | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | |
1.13.11.33 | 0.0022 | - |
IC50: 0.0022 mM | Homo sapiens | 2,3,5-tribromo-6-(3,5-dibromo-2-hydroxyphenoxy)phenol | |
1.13.11.33 | 0.004 | - |
IC50: 0.004 mM | Homo sapiens | 4,4'-propane-2,2-diylbis(2,6-dibromophenol) | |
1.13.11.33 | 0.005 | - |
IC50: 0.005 mM | Homo sapiens | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | |
1.13.11.33 | 0.005 | - |
IC50: 0.005 mM | Homo sapiens | 2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol | |
1.13.11.33 | 0.007 | - |
IC50: 0.007 mM | Glycine max | 2,3,4,5-tetrabromo-6-(2,4-dibromophenoxy)phenol | |
1.13.11.33 | 0.009 | - |
IC50: 0.009 mM | Glycine max | 3,4,6-tribromo-2-(2,4-dibromophenoxy)phenol | |
1.13.11.33 | 0.01 | - |
IC50: 0.01 mM | Homo sapiens | 2,4-dibromo-6-(2,4-dibromo-6-methoxyphenoxy)phenol | |
1.13.11.33 | 0.011 | - |
IC50: 0.011 mM | Homo sapiens | 3,4-dibromo-2-(5-bromo-2-hydroxyphenoxy)phenol | |
1.13.11.33 | 0.027 | - |
IC50: 0.027 mM | Glycine max | bestatin | |
1.13.11.33 | 0.027 | - |
IC50: 0.027 mM | Homo sapiens | bestatin 7 | |
1.13.11.33 | 0.034 | - |
IC50: 0.034 mM | Homo sapiens | 2,4-Dibromophenol | |
1.13.11.33 | 0.048 | - |
IC50: 0.048 mM | Glycine max | 4-Bromophenol | |
1.13.11.33 | 0.055 | - |
IC50: 0.055 mM | Homo sapiens | 4-Bromophenol | |
1.13.11.33 | 0.059 | - |
IC50: 0.059 mM | Homo sapiens | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | |
1.13.11.33 | 0.059 | - |
IC50: 0.059 mM | Glycine max | 3-[3-bromo-5-(2,6-dibromo-4-{2-[2-(3-bromo-4-hydroxy-phenyl)-ethylcarbamoyl]-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-methyl-phenyl]-N-[(E)-2-(3,5-dibromo-4-hydroxy-phenyl)-vinyl]-2-[(E)-hydroxyimino]-propionamide | |
1.13.11.33 | 0.1 | - |
IC50 above 0.1 mM: compound 1a, compound 1b, compound 1d, compound 1e, compound 1g | Homo sapiens | additional information |